The Laboratory Diagnosis of Crohn's Syndrome by W Jones Williams MD (Mount Vernon Hospital, Northwood, Middlesex) An attempt is being made to correlate Mantoux sensitivity with the histological findings. It is hoped that this will help in diagnosis, possibly in prognosis and in the study of the etiology, especially because there are no specific laboratory tests for this condition. The term Crohn's syndrome is preferred to that of Crohn's disease as it is a condition of unknown etiology and may well have more than one cause.
Two main types of inflarmnation have been described in a study of 61 casesnon-granulomatous, i.e. non-specific inflammation, in 20%, and granulomatous in 80 %. The latter are subdivided into diffuse 30%, consisting of admixed chronic inflammatory cells, histiocytes, foreign body and Langhans' type giant cells, and focal 50%. The focal granuloma and sometimes included Schaumann bodies, 10%, are considered to be identical with those of sarcoidosis (Williams, in preparation).
It is generally accepted that Crohn's and sarcoidosis are two distinct syndromes (Longcope & Freiman 1952) . The Kveim skin test further distinguishes them, as in 10 of my own cases the result was uniformly negative, as compared to sarcoidosis, with reported 86 % positive incidence (Siltzbach & Ehrlich 1954) . There is, however, a common denominator in that in both conditions the Mantoux test is negative in 70-80% (Blackburn et al. 1939 , Phear 1958 .
Twenty-four cases have been analysed, all with a clinical, macroscopic and often radiological confirmation of Crohn's syndrome, involving the ileum and/or colon. The results are seen in Table 1. Sixteen cases (67 %) are Mantoux negative at a dilution of 1/100 O.T. All with focal granuloma and 6 of the 11 with diffuse granuloma are Mantoux negative, while the 3 non-granulomatous cases are all positive. The numbers are too few to be conclusive but raise interesting possibilities and suggestions for further investigations. The results may help in deciding whether the two types of inflammation are related and, if so, which is the primary. This has never been proved, as so-called early cases may show one or the other. It suggests that the primary lesion is non-granulomatous with a positive Mantoux, changing with the development of diffuse granulomatous inflammation to focal granuloma with a negative reaction. Such a change in Mantoux reaction is not uncommon in many diseases, such as reticulosis and advanced malignancy. If these results are substantiated, those patients presenting with focal granuloma and a negative Mantoux are in reality 'late' cases and this could well have a bearing on prognosis and treatment, especially the indications for surgery. Another possibility is that the two main types of inflammation are not related and do not progress from one to the other; this supposition would be of value in determining the etiology. As a further part ofthis investigation, antigen is being prepared from diseased intestine and lymph glands in an attempt to demonstrate possible antigen-antibody reactions. Failure to show this in the past may have been due to lack of recognition and correlation of histology and 
